Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs) Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs)

Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs‪)‬

Clinical Chemistry 2006, Jan, 52, 1

    • $5.99
    • $5.99

Publisher Description

Because disease-causing microorganisms can be used as aerobiological weapons, accurate and timely identification of these agents is necessary (1-4). Important agents include Bacillus anthracis (anthrax), Brucella species (brucellosis), Clostridium botulinum (botulism), Coxiella burnetii (Q fever), Francisella tularensis (tularemia), Staphylococcus aureus, and Yersinia pestis (plague) (5). Real-time PCR can rapidly detect the presence of nucleic acid markers with small reaction volumes and rapid cycling. Assay chemistry is increasingly important in this identification process because the choices and concentrations of enzymes, buffers, salts, primers, and probes affect assay detection limits (6-12). Real-time PCR assays for detecting biological warfare agents have been developed on the R.A.P.I.D.[R] (Idaho Technology, Inc.), LightCycler[R] (Roche), and Smart Cycler[R] (Cepheid) platforms and are compatible with various fluorescence-based methods such as TagMan[R] (13, 14), hybridization probes (15, 16), molecular beacons (17-19), Scorpion primers (20), LUXE primers (21-24), AEGIS primers (25-27), and SimpleProbes[R] (IT Biochem). We investigated whether these assays produce comparable sensitivity and specificity on these rapid cycling instruments.

GENRE
Science & Nature
RELEASED
2006
January 1
LANGUAGE
EN
English
LENGTH
14
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
214.9
KB
Nucleic Acid Detection Technologies--Labels, Strategies, And Formats. Nucleic Acid Detection Technologies--Labels, Strategies, And Formats.
1999
Molecular Analysis and Genome Discovery Molecular Analysis and Genome Discovery
2011
PCR Applications (Enhanced Edition) PCR Applications (Enhanced Edition)
1999
Pcr-Oligonucleotide Ligation Assay from Dried Blood Spots (Technical Briefs) Pcr-Oligonucleotide Ligation Assay from Dried Blood Spots (Technical Briefs)
1999
Molecular Biomethods Handbook Molecular Biomethods Handbook
2008
Fully Automated, Homogeneous Nucleic Acid Detection Technology Based on Dry-Reagent Assay Chemistry and Time-Resolved Fluorometry (Abstracts of Oak Ridge Posters) Fully Automated, Homogeneous Nucleic Acid Detection Technology Based on Dry-Reagent Assay Chemistry and Time-Resolved Fluorometry (Abstracts of Oak Ridge Posters)
2007
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report) Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey) Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
2007
Alanine Aminotransferase As an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease (Letters) (Letter to the Editor) Alanine Aminotransferase As an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease (Letters) (Letter to the Editor)
2007
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology) T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
2007
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers) Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998